Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Cancer Res. 2014 Mar 13;74(10):2677–2687. doi: 10.1158/0008-5472.CAN-13-1996

Fig 4.

Fig 4

Kaplan-Meier log-rank survival analysis for CHD7 expression in patients receiving adjuvant therapy (n=59) and in patients receiving gemcitabine therapy (n=42). (A) Effect of CHD7 expression on recurrence-free survival (RFS) in patients receiving gemcitabine therapy (n=42). (B) Effect of CHD7 expression on overall survival (OS) in patients receiving gemcitabine therapy (n=42). (C) Effect of CHD7 expression on RFS in patients receiving adjuvant therapy (n=59). (D) Effect of CHD7 expression on OS in patients receiving adjuvant therapy (n=59).